Semler Scientific (NASDAQ: SMLR) reported Q4 EPS of $0.41, $0.13 better than the analyst estimate of $0.28. Revenue for the quarter came in at $13.8 million versus the consensus estimate of $13.1 million.

GUIDANCE:

Semler Scientific sees Q1 2023 revenue of $17.4-17.8 million, versus the consensus of $15.3 million.

• For the quarter ended March 31, 2023, Semler Scientific expects continued profitability and generation of cash from operating activities. Semler Scientific believes that first quarter revenue will range from $17.4 million to $17.8 million and pre-tax net income, which includes interest income of approximately $0.4 million, will range from $5.6 million to $5.8 million. In light of the CEO transition and the anticipated final CMS Rate Announcement, Semler Scientific is not issuing guidance for the year ended December 31, 2023 at this time.

For earnings history and earnings-related data on Semler Scientific (SMLR) click here.